Skip to main content
Clinical Trials/JPRN-UMIN000045557
JPRN-UMIN000045557
Completed
未知

Multicenter prospective study on prediction of primary resistance to anti PD-1/PD-L1 antibodies by hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI - PREDICT study

Kindai University0 sites165 target enrollmentSeptember 24, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Kindai University
Enrollment
165
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 24, 2021
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with malignant tumor of other organ that is difficult disease control 2\) Patients with esophagogastric varices at high risk of rupture 3\) Patients who are pregnant or who wish to have a baby during treatment 4\) Refusal to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials